Bokobza, Cindy
Réda, Clémence
Nair, Syam
Guenoun, David
Rocha-Ferreira, Eridan
Faivre, Valérie
Le Charpentier, Tifenn
Nijboer, Cora
de Theije, Caroline
Lebon, Sophie
Ek, Joakim
Hafez, Mohamed Gaeth
Schwendimann, Leslie
Benchouaia, Médine
Lemoine, Sophie
Volpi, Giorgia
Dallaglio, Katiuscia
Pelizzi, Nicola
Fleiss, Bobbi
Van Steenwinckel, Juliette
Delahaye-Duriez, Andrée
Hagberg, Henrik
Gressens, Pierre
,
Funding for this research was provided by:
European Union (874721/PREMSTEM)
Article History
Received: 16 July 2025
Accepted: 8 October 2025
First Online: 23 December 2025
Declarations
:
: Not applicable.
: Not applicable.
: This research was conducted within the funding framework of PREMSTEM, a Horizons 2020 funded consortium (grant agreement no. 874721/PREMSTEM) The HuMSC used in this study were provided by Chiesi Farmaceutici, one of the members of the consortium. Chiesi Farmaceutici played no part in the design, execution and analysis of the data and did not play a role in the decision to publish or the data to be published. Their permission to publish has been obtained.